Clinical Trials Logo

Articular Disease clinical trials

View clinical trials related to Articular Disease.

Filter by:
  • None
  • Page 1

NCT ID: NCT06248307 Active, not recruiting - Clinical trials for Overweight and Obesity

Evaluation of Protein Bars on Weight Management and Osteoarthicular Health

COLARTIC
Start date: November 15, 2023
Phase: N/A
Study type: Interventional

The goal of this intervention study is to evaluate the efficacy in subjects with overweight or obesity of protein bars consumption. The main questions it aims to answer are: - Does the regular consumption of these protein bars help to loose weight? - Does the regular consumption of these protein bars help to improve the osteoarticular health? Participants will be asked to follow the indications of consumption of the bars togather with healthy nutritional advice during 16 weeks. Researchers will compare exparimental Versus placebo groups to see if weight is lost in similar or different ways.

NCT ID: NCT05007405 Completed - Articular Disease Clinical Trials

Spectrum of Bacterial Infections in Rheumatology

SIBERIE
Start date: February 12, 2021
Phase:
Study type: Observational

Retrospective study of patients with a proved non-tuberculous osteoarticular infection (OAI) diagnosed in a rheumatology department during the years 2010-2020. The objectives are : - To describe sites, type of micro-organism, clinical data, origin of infection, therapeutic modalities et outcome - To compare OAI of urinary origin with those with another origin

NCT ID: NCT04842071 Recruiting - Infectious Disease Clinical Trials

18F-sodium Fluoride (NaF) PET to Replace Bone Scintigraphy: Safety and Efficacy Assessment

Start date: January 1, 2008
Phase: Phase 3
Study type: Interventional

18F-sodium fluoride (18F-NaF) was already investigated numerous times in the last 40 years as a PET alternative to standard 99m-technetium-derived bone scintigraphy. However, lack of universal tracer availability and higher costs contributed to the failure of 18F-NaF to systematically supplant bone scintigraphy as a standard of care. Recently, an isotope shortage crisis occurred and evidenced the need to have non-reactor-derived alternatives for many nuclear medicine procedures, including bone scintigraphy. Since 18F-NaF is cyclotron-produced, it could become a necessary alternative to bone scintigraphy in case of another worldwide isotope shortage. The study aims to evaluate the safety profile of 18F-NaF injection. Moreover, a patient registry will be compiled in order to perform sub-studies on 18F-NaF diagnostic performance on diverse bone and articular diseases.